Align is a platform that centralizes customer conversations across various data sources, utilizing AI to automatically analyze feedback and identify trends, product gaps, and win/loss reasons. By providing instant, verified answers to sales teams, Align reduces response times and enhances the efficiency of customer interactions, saving over 10 hours per sales engineer each week.

Brella is a web-based event management platform that utilizes AI-driven matchmaking to enhance networking opportunities for attendees at conferences and events. The platform offers customizable mobile apps and real-time analytics, enabling organizers to improve engagement and measure event performance effectively.

Cardiac Success develops the Vsling, a transcatheter ventricular repair device designed to reshape the left ventricle in patients with heart failure and reduced ejection fraction. This device addresses the deterioration of cardiac function by initiating therapeutic remodeling, thereby improving symptoms and enhancing patients' quality of life.

CART Medical develops proprietary immune cell therapies targeting solid tumors through advanced recognition and activation mechanisms. The company aims to enhance treatment efficacy and accelerate the clinical application of these therapies, addressing the limitations of current cancer treatments.

Develops the CoFI System, a medical device that diagnoses microvascular obstruction (MVO) in real-time during percutaneous coronary interventions (PCI) using existing guide catheters and wires. It provides rapid, accurate detection of MVO, a condition affecting up to 60% of acute heart attack patients, and enables controlled delivery of therapeutic agents directly into the vasculature to improve patient outcomes.

Endovascular Engineering, Inc. develops the Hēlo™ PE Thrombectomy System, which utilizes a self-expanding funnel design and dual-action technology to effectively engage and remove clots in patients with venous thromboembolism. This system addresses the challenges of navigating complex anatomies while minimizing hemodynamic impact through its small profile and large bore performance.

HiLo is a platform that automatically tracks key gaming milestones and competitive statistics, such as rank-ups and top damage, starting with DOTA 2. It creates a shared social experience for gamers, allowing them to celebrate their achievements in real-time rather than losing them in chat histories.

Intact Vascular develops minimally-invasive medical devices for peripheral vascular procedures, utilizing real-time imaging and guidance technologies to enhance the precision of device placement. Their solutions address the challenges of vessel occlusions and aneurysms, enabling clinicians to perform faster and safer interventions while improving patient outcomes.

This company develops photoacoustic imaging technology for real-time visualization of anatomical, functional, and molecular information within living tissue. Their technology enables non-invasive detection of tumors and inflammatory diseases.

Laza Medical develops an intelligent imaging system powered by AI and robotics to simplify cardiac procedures like structural heart and electrophysiology interventions. The platform integrates real-time 3D heart modeling, procedural guidance, and robotic probe control to enhance image acquisition and interpretation. This technology aims to increase procedural autonomy for clinicians and expand patient access to necessary cardiac care.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

The startup develops a fluid-drive system that enables precise navigation of flexible delivery catheters for structural heart therapies, allowing cardiologists to perform life-saving heart valve procedures with the ease of cursor movement on a digital interface. This technology addresses the challenge of delivering complex cardiac interventions with accuracy and control in minimally invasive surgeries.

Motion provides a platform that integrates visual content with performance metrics, enabling growth teams to analyze competitor ads and optimize their creative strategies. By offering tools for tracking paid social campaigns and accessing expert ad collections, Motion enhances the effectiveness of advertising efforts and drives revenue growth.

R3 Vascular develops bioresorbable polymer scaffolds using a proprietary manufacturing process to treat peripheral artery disease. These scaffolds provide a temporary support structure that promotes vascular healing while gradually resorbing, addressing the need for effective and less invasive treatment options.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

Rebound Therapeutics develops medical devices for neurosurgery, wound reconstruction, and surgical reconstruction, focusing on dural access, cerebral spinal fluid management, and soft tissue repair. Their technologies address the challenges of complex wounds, burns, and surgical recovery, enhancing patient outcomes through evidence-based solutions.

Sent provides a unified API that enables brands to send messages across multiple channels, including SMS, WhatsApp, and iMessage, while optimizing delivery based on real-time channel performance and user engagement data. This technology reduces messaging costs by 80-90% and simplifies integration for developers, allowing them to focus on product development rather than managing multiple messaging services.

The startup develops augmented reality software that overlays 3D radiology images onto real-world environments, enhancing pre-surgical planning and education for clinicians. This technology enables healthcare professionals to visualize complex anatomy more effectively, improving surgical efficiency and patient understanding.

Stic operates a mobile out-of-home advertising network by equipping high-mileage drivers with ad placements. The platform allows brands and agencies to execute geo-targeted campaigns with real-time impression tracking and performance monitoring. This system converts daily commutes into measurable media inventory for targeted audience reach.

TR Corporation develops AI-driven smart healthcare devices and electronic products in collaboration with medical professionals and researchers. Their technology addresses the need for advanced health monitoring solutions, enhancing patient care and promoting healthier lifestyles.

This company offers a lead generation and management platform that uses machine learning to optimize ad copy and landing pages for higher conversion rates. It also provides cloud-based call center software with predictive lead scoring and routing to improve sales efficiency.

Provides a centralized platform for discovering and distributing flexible commercial real estate (CRE) inventory, streamlining transactions for brokers, operators, and aggregators. By processing $4.8 billion in contract value since 2020, it enables faster occupancy matching, improved inventory access, and increased revenue generation in the flexible workspace sector.

Vesper Medical develops the Vesper DUO Venous Stent System®, engineered to address the anatomical challenges of the deep venous system in patients with Chronic Venous Insufficiency (CVI). This next-generation stent portfolio reduces the need for multiple stent types in the iliofemoral segment, streamlining treatment and improving patient outcomes.